EN
抗体药类似物
Research Grade Vedolizumab
All
TD-HY596026_1.jpg
TD-HY596026_2.jpg
  • CatalogTD-HY596026
  • ClonalitymAb
  • Application Research Grade Biosimilar
  • SynonymsLDP-02,LDP02,MLN-02,MLN0002,MLN02,CAS:943609-66-3
  • 规格
    1mg
  • 价格
    ¥询价
定制服务咨询

Research Grade Vedolizumab


Catalog No. TD-HY596026
Species reactivity Human
Applications Research Grade Biosimilar
Host species Humanized
Isotype IgG1-kappa
Expression system Mammalian Cells
Clonality Monoclonal
Target ITGA4, CD49d, CD49 antigen-like family member D, CD49D, VLA-4 subunit alpha, Integrin alpha-IV, Integrin alpha-4, Gut homing receptor beta subunit, Integrin beta-7, ITGB7
Endotoxin level Please contact the lab for this information.
Purity >95% purity as determined by SDS-PAGE.
Purification Protein A/G, purified from cell culture supernatant.
Accession P13612 & P26010
Form Liquid
Storage buffer 0.01M PBS,pH7.4.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
Alternate Names LDP-02,LDP02,MLN-02,MLN0002,MLN02,CAS:943609-66-3
Background Vedolizumab is a humanized IgG1 monoclonal antibody that targets the α4β7 integrin for the treatment of ulcerative colitis and Crohn's disease.
Note For research use only. Not for use in clinical or therapeutic applications.

 

TD-HY596026_1.jpg
Bioactivity
 
SEC-HPLC detection for Research Grade Vedolizumab.
TD-HY596026_2.jpg
SDS-PAGE
 
SDS-PAGE for Research Grade Vedolizumab.